This article gives insight into legal action against Gilead. The company is accused of making deals to block the development of generic versions of their medications. Especially anything with tenofovir, the base for many of the company's medications, notably Truvada (PrEP). These same deals would also mostly eliminate any competition over cost. Gilead would face no competition in the market.
There are many articles covering this development. This was the most user friendly & easily available. Give it & maybe them a read. Take care.
Cya...
No comments:
Post a Comment